echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > A large number of hospitals stop using 20 heavy varieties

    A large number of hospitals stop using 20 heavy varieties

    • Last Update: 2019-12-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Fujian has always been the experimental field and pioneer army of medical reform pilot, whether in Sanming mode or in the first linkage of 4 + 7, which endows the province with the temperament and style of actively seeking change This time, it will kick the key monitoring drugs out of the public hospital market, or play a leading role in other provinces ▍ 20 varieties, basically bid farewell to Fujian market yesterday (December 10), Fujian Medical Security Bureau issued a document, classified and adjusted the online catalog of joint limited price sunshine procurement, deleted the varieties listed in the national key monitoring items in the catalog deletion item - 20 varieties, basically bid farewell to Fujian market Since the National Bureau released the first batch of national key monitoring and rational drug use catalogue, many provinces and cities have also directly followed up the implementation, released the local version of the key monitoring catalogue, and basically included these 20 varieties To some extent, the policy of Fujian Province is the most powerful, which means that at least 20 varieties have withdrawn from the public hospital market of Fujian Province According to the "number of national medical and health institutions by the end of September 2019" released by the statistical information center of China government network, there are 27710 medical and health institutions in Fujian, including 657 hospitals, 26517 primary medical institutions and 451 professional public health institutions In other words, the public hospitals, which account for a large proportion of 657 hospitals, are about to eliminate these 20 drugs Fujian said that in order to further improve the joint price limit sunshine purchase mechanism of drugs, ensure the clinical drug demand, improve the efficiency of medical insurance fund, and promote rational drug use, it was decided to adjust the online catalog of joint price limit sunshine purchase by classification after research Special adjustment: Catalog supplement: for drugs of category A and national essential drugs of medical insurance, they can be supplemented after comprehensive evaluation; for new category B drugs of national medical insurance in the current round, they can be supplemented through expert selection, and the specific scheme will be formulated separately; for drugs of national negotiation, they will be linked to the Internet according to the requirements of relevant documents Catalog deletion: the varieties listed in the national key monitoring shall be deleted; the varieties excluded from the national medical insurance catalog shall be deleted according to the provisions of drug supervision and administration; the varieties excluded from the other national medical insurance catalogs shall be included in the scope of expert key demonstration and evaluation The documents are clear For the newly added catalogue, the first batch of products are linked to the Internet through inquiry, and then the product linked to the Internet is adjusted dynamically according to the current rules For the first batch of products that are added to the linked catalogue according to the consistency evaluation of quality and efficacy of generic drugs, it is determined that no more than three evaluated drugs will be linked to the Internet according to the quotation from low to high, and then the product linked to the Internet according to the current rules Line dynamic adjustment, no additional hanging net for generic drugs without review And belongs to delete directory, all products under the directory shall be removed from the network Among them, those that can be legally marketed and sold according to the provisions of drug supervision and administration can be purchased according to the provisions of the notice on printing and distributing (min medical insurance office [2017] No 130) issued by the original provincial medical insurance office and the provincial health and family planning commission if there is any clinical demand ▍ on July 1, the state health and Health Commission issued the "notice on printing and distributing the first batch of national key monitoring and rational drug use catalogue (chemical and biological products)" The document published 20 catalogues of chemical drugs and biological products, requiring all medical institutions to establish key monitoring and rational drug use management system, and strengthen the whole process management of clinical application of drugs in the catalogue In order to ensure rational drug use, measures such as ranking notification, rectification within a time limit and clearing out the drug supply catalogue of the agency shall be taken for the varieties with prominent unreasonable drug use problems In the new version of the medical insurance catalogue released later, the state will focus on monitoring the transfer out of the payment scope of drugs and cracking down on auxiliary drugs In the past, the medical insurance catalogue was generally loose, and the drugs transferred out were seldom used The new version of the catalogue directly transferred the national key monitoring catalogue out of the scope of payment, indicating the determination of the medical insurance bureau to limit the use of invalid auxiliary drugs in the medical insurance fund In addition, the prohibition of local supplement of medical insurance catalogue also cut off the "curve saving" plan of pharmaceutical enterprises According to the document, each province is not allowed to add drugs on its own The class B drugs added in the original provincial catalog should be gradually digested within three years Saberan has also confirmed from authoritative channels that the arrangements for the transfer out of varieties in the local supplementary medical insurance catalog are as follows: 1 Drugs in the key monitoring catalog are moved out of the medical insurance catalog first; 2 In principle, other local supplementary catalogs are cleaned up within three years, with the proportion of varieties cleaned up in three years being 40%, 40% and 20% respectively In the past, some of the varieties in the catalogue failed to enter the national version of the medical insurance catalogue, but they were frequent customers of local supplementary medical insurance catalogue This curve medical insurance reimbursement scheme was terminated, which also had a fatal impact on related enterprises.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.